The disposable blood bags market is valued at USD 275.3 million in 2021 and is poised to grow at a significant CAGR of 5.1% over 2022–2028. The ability to deliver particular services has expanded as a result of the expanding capacity of healthcare facilities such hospitals, patient care facilities, diagnostic centres, and clinics, as well as blood banks. There is a high demand for whole blood and other blood components to make up for blood loss before or during procedures due to medical crises and communicable diseases. Hospitals rely on internal and independent blood banks to meet the rising demand for blood and blood components, which propels market expansion. There are numerous products made by medical and surgical equipment producers that are exclusively meant for one use. The main justification is infection control; since each item is only used once, it cannot spread infectious pathogens to more patients. They are crucial for patient care at the bedside, in rural health clinics, or in large, specialised hospitals, just as medicines and other health technologies.
Recent Market Developments:
In Nov 2019, Grifols announced the start of production at its new blood-collection systems plant in Campo Largo, Brazil, which has a capacity of more than 10 million blood collection bags yearly.